Efficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome

Medical University of Vienna - Medizinische Universität Wien, Vienna

Cukurova University Faculty of Medicine, Sarıçam

Wesley Hospital, Auchenflower

Children's Health Queensland Hospital, South Brisbane

Aarhus University Hospital, Aarhus

Hospital Sant Joan de Deu Barcelona, Barcelona

Johns Hopkins University Medical Center, Baltimore

Università degli Studi di Brescia, Scienze Cliniche e Sperimentali, Brescia

Hospital Universitario Virgen del Rocío, Seville

University of Iowa, Iowa City

CHU de Lyon, Institut d'Hematologie et d'Oncologie Pediatrique, Lyon

CHU Paris Est, Hôpital d'Enfants Armand-Trousseau, Paris

Hopital Necker-Enfants Malades, Paris

California Dermatology Institute, Thousand Oaks

University of California San Diego Health/Rady Children's Hospital, San Diego

University of Washington Medical Center, Seattle

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow

Academician I.P. Pavlov First Saint Petersburg State Medical University, Saint Pertersburg

HaEmek Medical Center, Afula

University of Texas Southwestern Medical Center, Dallas

University of Debrecen, Affiliated Department of Infectology, Debrecen

Emma Children's Hospital Academic Medical Center (AMC), Amsterdam

Seoul National University Hospital, Children's Hospital, Seoul